Ghrelin binding nucleic acids

Details for Australian Patent Application No. 2006233647 (hide)

Owner Noxxon Pharma AG

Inventors Eulberg, Dirk; Klussmann, Sven; Jarosch, Florian; Helmling, Steffen; Maasch, Christian

Agent Pizzeys

Pub. Number AU-A-2006233647

PCT Pub. Number WO2006/108599

Priority 05007795.7 08.04.05 EP

Filing date 10 April 2006

Wipo publication date 19 October 2006

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/108599 Priority application(s): WO2006/108599

17 April 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 25 Sep 2007

27 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006233661-Protected vehicle or ship

2006233642-Method of peptide synthesis